BioCatalyst

LRMR — Larimar Therapeutics, Inc. catalysts

1 verified catalyst event(s) for Larimar Therapeutics, Inc. (ticker LRMR). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2027-01-01 — An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01 (month)
in 3mo
ESTIMATED
 READOUT
An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia
Phase 2 · Friedreich Ataxia
 LRMR Larimar Therapeutics, Inc. CTI-1601 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.